There’s Still Little Proof To Back Up Hype Over Combination Cancer Immunotherapies

By May 17, 2018 News No Comments

All the buzz over combining experimental immune-boosting drugs with checkpoint inhibitors could fizzle into disappointment. In other public health news: eye treatments, aging athletes, the E. coli outbreak, hearing aids, and Ebola.

Via::